Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital
Authors:
- Jan M. PrinsJPJan M. Prins
- Jaap DankertJDJaap Dankert
Open Access
- 1 April 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 43 (4) , 601-606
Abstract
In recent years ‘switch therapy’ has been advocated: short intravenous antibiotic therapy, for 2- 3 days, followed by oral treatment for the remainder of the course. Little is known about the number of patients that could benefit from early switch therapy and the consequences of introducing this strategy in everyday practice. We prospectively registered all antibiotic courses on wards for Internal Medicine, Surgery, and Pulmonology during a 2 month period, before (n=362, inventorial phase) and after (n=281, implementation phase) the introduction of guidelines for switching therapy. Approximately 40% of all patients who started on iv antibiotics were candidates for an early iv- oral switch. During the inventorial phase, 54% (52/97) of eligible patients were switched to oral treatment, after a median of 6 days (range 2- 28 days). After implementation of the guidelines, this percentage rose to 83% (66/80) (difference 29%, 95% CI 16- 42%; P < 0.001). Therapy was also switched earlier, after a median of 4 days (range 2 to 16 days). In the 6 weeks after completion of the oral course, recurrence of infections, or readmissions due to reinfections did not occur. Compared with the inventorial phase, 43% of iv administrations could be avoided, that is c.US$30,000) of administration costs. The potential savings in purchase costs of the antibiotics were dfl.54,000 (US$27,000) annually. In conclusion, a substantial number of patients starting on iv antibiotics were candidates for an early iv- oral switch. The guidelines were well accepted by the physicians and substantial savings in costs and nursing time were achieved.Keywords
This publication has 23 references indexed in Scilit:
- Oral Administration of Antibiotics: A Rational Alternative to the Parenteral RouteClinical Infectious Diseases, 1997
- A Prospective Randomized Study of Inpatient IV Antibiotics for Community-Acquired PneumoniaChest, 1996
- Switch therapy: the theory and practice of early change from parenteral to non-parenteral antibiotic administrationClinical Microbiology and Infection, 1996
- Sequential Antibiotic Therapy: Effective Cost Management and Patient CareCanadian Journal of Infectious Diseases and Medical Microbiology, 1995
- Efficacy and tolerance of cefotaxime followed by oral cefixime versus cefotaxime alone in patients with lower respiratory tract infectionsCurrent Therapeutic Research, 1994
- Ciprofloxacin versus a Tobramycin/Cefuroxime Combination in the Treatment of Serious Systemic Infections: A Prospective, Randomized and Controlled Study of Efficacy and SafetyScandinavian Journal of Infectious Diseases, 1992
- Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibioticsThe American Journal of Medicine, 1991
- Brief report: randomized study of intravenous versus sequential intravenous/oral regimen of ciprofloxacin in the treatment of gram-negative septicemiaThe American Journal of Medicine, 1989
- Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infectionsThe American Journal of Medicine, 1989
- Sequential Intravenous-Oral Administration of Ciprofloxacin vs Ceftazidime in Serious Bacterial Respiratory Tract InfectionsChest, 1989